Characteristics of the entire patient cohort discharged from our clinic over one year and divided into subgroups. The differences in age, gender, time from cancer diagnosis to referral to the GIANT service and body mass index were compared between patients treated with pelvic radiotherapy and those treated with other cancer treatment modalities using the sign test.
| Characteristics | Clinic population (n = 325) | Treated with pelvic radiotherapy (n = 220) | Treated with other treatment modalities (n = 105) | Sign test, p |
|---|---|---|---|---|
| Age (years), median (range) | 68 (20–90) | 68 (21–90) | 65 (20–85) | <0.001 |
| Gender | 0.001 | |||
| Male | 183 (56) | 139 (63) | 45 (43) | – |
| Female | 142 (44) | 81 (37) | 60 (57) | – |
| Years from diagnosis to referral to GIANT, median (range) | 3.4 (0.1–42.2) | 3.6 (0.2–38.7) | 2.0 (0.1–42.2) | 0.001 |
| Body mass index, median (range) | 25.1 (14.4–47.8) | 24.1 (15.7–47.8) | 26.2 (14.4–47) | <0.001 |
| Urological cancer | 143 (44) | 126 (57) | 17 (16) | N/A |
| Prostate cancer | 128 (98) | 120 (95) | 8 (47) | |
| Gynaecological cancer | 67 (21) | 57 (26) | 10 (10) | N/A |
| Cervical cancer | 28 (42) | 28 (49) | 0 (0) | |
| Colorectal cancer | 37 (11) | 29 (13) | 8 (8) | N/A |
| Rectal cancer | 22 (59) | 17 (59) | 5 (63) | |
| Upper gastrointestinal cancer | 34 (10) | 3 (1) | 31 (29) | N/A |
| Gastric cancer | 11 (32) | 0 (0) | 11 (35) | |
| Head and neck cancer | 5 (2) | 0 (0) | 5 (5) | N/A |
| Thyroid cancer | 4 (80) | 0 (0) | 4 (80) | |
| Haematology | 23 (7) | 2 (1) | 21 (20) | N/A |
| Multiple myeloma | 5 (22) | 0 (0) | 5 (24) | |
| Other cancer diagnoses | 16 (5) | 3 (1) | 13 (12) | N/A |
| Breast cancer | 7 (44) | 1 (33) | 6 (46) |
Data are n (%) unless otherwise specified. GIANT = GI [gastrointestinal] and Nutrition Team; N/A = not applicable.